当前位置:首页 - 行情中心 - 奥泰生物(688606) - 财务分析

奥泰生物

(688606)

  

流通市值:32.51亿  总市值:32.51亿
流通股本:7928.09万   总股本:7928.09万

奥泰生物(688606)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.19亿元,每股收益0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益388226.47万元,未分配利润195549.65万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产410905.64万元,负债22679.17万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入195,372,450.28905,344,393.81633,076,568.3429,850,024.75
营业总成本178,180,947.39711,573,116.92457,636,927.5299,110,577.78
其他经营收益
营业利润21,643,668.11251,810,099.85218,808,577.65152,580,872.91
利润总额21,759,923.13251,176,669.04218,245,963.24152,107,387.74
净利润19,130,988.4220,071,907.4189,723,134.17132,101,804.86
每股收益
其他综合收益308,042.58-361,475.92-608,935.67-647,348.27
综合收益总额19,439,030.98219,710,431.48189,114,198.5131,454,456.59
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,692,006,061.632,831,759,538.422,927,645,354.462,890,971,208.9
非流动资产:
非流动资产合计1,417,050,296.611,410,665,422.251,314,380,983.961,263,041,140.27
资产总计4,109,056,358.244,242,424,960.674,242,026,338.424,154,012,349.17
流动负债:
流动负债合计217,834,785.06286,644,560.7329,541,409.28243,218,757.13
非流动负债:
非流动负债合计8,956,870.969,441,456.3511,137,443.033,036,861.45
负债合计226,791,656.02296,086,017.05340,678,852.31246,255,618.58
所有者权益(或股东权益):
归属于母公司股东权益合计3,882,888,640.383,946,690,966.343,901,773,832.633,907,884,829.09
股东权益合计3,882,264,702.223,946,338,943.623,901,347,486.113,907,756,730.59
负债和股东权益合计4,109,056,358.244,242,424,960.674,242,026,338.424,154,012,349.17
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计203,591,692.47969,568,433.87671,775,561.77450,978,874.54
经营活动现金流出小计235,773,519.52762,975,443.49557,315,959.78389,625,238.79
经营活动产生的现金流量净额-32,181,827.05206,592,990.38114,459,601.9961,353,635.75
投资活动产生的现金流量:
投资活动现金流入小计987,653,036.972,101,166,416.221,661,986,279.021,340,220,271.23
投资活动现金流出小计174,049,615.711,955,492,072.061,582,074,613.041,094,140,912.37
投资活动产生的现金流量净额813,603,421.26145,674,344.1679,911,665.98246,079,358.86
筹资活动产生的现金流量:
筹资活动现金流入小计286,068.7820,003,703.7710,357,453.013,396.29
筹资活动现金流出小计86,152,015.46198,008,723.05118,677,423.8118,143,367.6
筹资活动产生的现金流量净额-85,865,946.68-178,005,019.28-108,319,970.79-118,139,971.31
汇率变动对现金及现金等价物的影响-14,518,117.23-11,836,543.94-5,492,523.53-630,750.5
现金及现金等价物净增加额681,037,530.3162,425,771.3280,558,773.65188,662,272.8
期末现金及现金等价物余额1,748,017,537.211,062,762,726.91980,895,729.241,088,999,228.39
补充资料:
现金及现金等价物的净增加额-162,425,771.32-188,662,272.8
TOP↑